Hair Loss After Extracorporeal Membrane Oxygenation

July 2003 in “ Pediatric Critical Care Medicine ”

Robert Pettignano, Micheal Heard, Michele D. Labuz, Scott Wagoner, James D. Fortenberry

extracorporeal membrane oxygenation hair loss telogen effluvium stressors hair regrowth ECMO TE

Studysummary This study observed that hair loss, which resolved on its own within six months, was reported by some patients after extracorporeal membrane oxygenation, suggesting it as a potential side effect.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research Telogen Effluvium: Acute and Chronic Hair Loss Conditions

32 citations , October 2009 in “Dermatology”

This article describes acute and chronic telogen effluvium, highlighting the importance of differentiating them from androgenetic alopecia for accurate diagnosis and treatment strategies but includes no new clinical research findings.

research Telogen Effluvium: Causes, Diagnosis, and Treatment

144 citations , July 2002 in “Clinical and Experimental Dermatology”

This article reviews the concept of telogen effluvium and emphasizes the importance of identifying triggers and using diagnostic investigations to determine the cause of hair loss, without reporting new results.

research Hair and Systemic Disease

58 citations , October 2001 in “Dermatologic Clinics”

This review discusses the categorization of hair loss and increased hair density disorders related to systemic diseases and reports no clinical results, emphasizing the potential diagnostic value of history, physical examination, and histopathologic data.

research Drug-Induced Hair Loss and Hair Growth

147 citations , April 1994 in “Drug Safety”

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

research Telogen Effluvium: An Etiopathogenetic Theory

13 citations , May 1993 in “International Journal of Dermatology”

This article presents a theory on the causes and development of telogen effluvium and reports no new clinical findings.

research Telogen Effluvium: A Comprehensive Review

214 citations , March 1993 in “Archives of Dermatology”

This article proposes five different mechanisms for telogen effluvium, supported by clinical findings, based on changes in different phases of the hair cycle.

research Postfebrile Telogen Effluvium in Critically Ill Patients

21 citations , January 1988 in “Critical Care Medicine”

Critically ill patients may experience temporary hair loss after a fever.

research Hair Loss in Systemic Disease

24 citations , July 1987 in “Dermatologic Clinics”

This article reviews various causes of hair loss linked to systemic factors, noting that careful history and examination can lead to accurate diagnosis, but reports no new clinical results.

research Telogen Effluvium After Anesthesia and Surgery

12 citations , January 1984 in “Anesthesia & Analgesia”

This abstract provides only publication and correspondence details; it does not present any study findings or results.

research Alopecia in Crash Dieters

32 citations , June 1976 in “JAMA”

In this study, nine individuals who underwent rigorous weight loss programs experienced significant hair loss, which researchers attributed to insufficient energy supply to the hair matrix, with regrowth occurring within months.